Rohto Pharmaceutical Co.,Ltd. (RPHCF)

20.49 0.00 (0.00%) At close: 04:36PM EDT

Rohto Pharmaceutical Co.,Ltd.

1-8-1, Tatsumi-nishi
Ikuno-ku
Osaka 544-8666
Japan
81 6 6758 1231
https://www.rohto.co.jp

Sector(s): Consumer Defensive
Industry: Household & Personal Products
Full Time Employees: 7,176

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Yamada Kunio	Chairman of the Board & CEO	1.34M	N/A	1956
Mr. Masashi Sugimoto	President & Representative Director	N/A	N/A	1961
Mr. Saito Masaya	VP, CFO & Director	N/A	N/A	1963
Mr. Shinichi Kunisaki	EVP, CTO & Director	N/A	N/A	1955
Ms. Yoshie Ohkouchi	Chief Communication Officer & Director	N/A	N/A	1969
Mr. Hideto Kamimura	Senior Executive Officer and General Manager of Marketing Division	N/A	N/A	N/A
Mr. Yasunori Kawasaki	CHRO & Director	N/A	N/A	1960
Hidetoshi Segi	MD, Chief Strategy Officer & Director	N/A	N/A	1962

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Rohto Pharmaceutical Co.,Ltd. manufactures and markets pharmaceutical products, cosmetics, and functional foods worldwide. The company provides eye care products, such as eye drops, care for contact lenses, and eye wash; and facial care products comprising face wash, lotions, and creams. It also offers medicine and medicated products for skin, lip balms, sunscreens, functional cosmetics, etc.; medicine for internal use, such as digestive and herbal medicines; regenerative medicines; OTC pharmaceutical products, including ophthalmic, dermatological, gastrointestinal, and diagnostic drugs, as well as Chinese herbal medicines, and supplements. In addition, the company operates beauty counters that provide beauty and health services; and manufactures and sells diagnostic reagents, as well as provides investment management services; and contract development and manufacturing services. The company was formerly known as Yamada Pharmaceutical and changed its name to Rohto Pharmaceutical Co.,Ltd. in September 1949. Rohto Pharmaceutical Co.,Ltd. was founded in 1899 and is headquartered in Osaka, Japan.

Corporate Governance

Rohto Pharmaceutical Co.,Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.